U.S. Attorney General Pam Bondi accused Luigi Mangione, 26 — on trial in the shooting death of UnitedHealthcare CEO Brian Thompson — of committing a "cold-blooded assassination.” President Donald ...

He is awaiting trial in the slaying of UnitedHealthcare CEO Brian Thompson. Meanwhile, the FBI has found no credible terrorist threat directed at hospitals. NBC News: Hidden Heart-Shaped Notes Were ...

It did not take long for Pfizer Inc. (NYSE:PFE) to change its mind on its oncology pipeline approach – after the deal with Summit Therapeutics Inc. (SMMT) in February for co-development of ...

Pfizer Inc. plans to spend billions of dollars to join the race for a new type of cancer treatment. Similar to its competitors, Pfizer also plans to partner with a Chinese company. The company PFE ...

Pfizer's licensing deal with China's 3Sbio for PD-1/VEGF antibody has an upfront payment more than double what Merck paid last year for its deal with China's LaNova Pfizer Inc. plans to spend ...

Emilio Parra Doiztua / Bloomberg / Getty Images Pfizer said late Monday that it has agreed to a deal to help develop and market a Chinese cancer drug across the globe. Chinese firm 3SBio is ...

Pfizer announces a licensing agreement with 3SBio to develop, manufacture and commercialize SSGJ-707 globally, excluding China. Ready to turn the market’s comeback into steady cash flow?

After the shooting of UnitedHealthcare CEO Brian Thompson in December, physicians offered a sober look at frustrations with the healthcare system in the U.S. Photo illustration: WSJ ...

Pfizer has joined the PD-1xVEGF bispecific gold rush. The Big Pharma is paying 3SBio $1.25 billion upfront for ex-China rights to a clinical candidate, establishing itself as a challenger to ...

Kansas Attorney General Kris Kobach's lawsuit against Pfizer over COVID-19 vaccine marketing has been returned to state court. Kobach alleges Pfizer violated the Kansas Consumer Protection Act ...

May 19 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said it would license an experimental cancer treatment from China's 3SBio Inc (1530.HK), opens new tab, paying $1.25 billion upfront ...

Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the ...